Additionally, individuals with a BMI of 27 or greater who also have conditions such as high blood pressure , type 2 diabetes, or high cholesterol may qualify for this treatment
Kyrtata N, Emsley HCA, Sparasci O, Parkes LM, Dickie BR
1,190 - Rs
Conclusion Rybelsus can be an effective medication for blood sugar control in type 2 diabetes, but the medication is associated with certain side effects
[23] [24] The combined cardiovascular impact of both agents in the same individual therefore remains unknown, and no favourable cardiovascular outcome should be assumed
How PlexusDx Supports a More Personalized Approach Individual genetic variation explains why some patients achieve rapid weight loss and metabolic improvement on GLP-1 therapy while others see slower response